A study of Gorochanadi Vati as an add on efficacy in moderate and severe Covid - 19 Positive subjects with reduced oxygen saturation - Covid-19

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1. Typical or atypical clinical presentation of acute onset febrile illness with sore throat and dry cough with or without shortness of breath and a RT_PCR based laboratory confirmation test for COVID-19
•2. Patients with either gender, 21 to 70 years age
•3. Patients with moderate and severe Covid â?? 19 disease with SPO2 less than 94%
•4. Patients willing to participate and sign an informed consent Understands and agrees to comply with planned study procedures.

•1. Patients suffering from COVID-19 Disease with SpO2 level below 80% as judged by a physician
•2. Severe, Unstable, Uncontrolled co-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study
•3. Active cancer diagnosis, on palliative treatment or requiring current therapy with antimetabolic agents, immunotherapy or radiotherapy.
•4. Patients on complete parenteral nutrition
•5. Patients who are likely to worsen or ventilator support due to any reason
•6. Pregnancy and lactation
•7. Physician decision that involvement in the study is not in the patientÂ´s best interest

发起方

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan